For those interested, my Forbes articles this month have been focused on price disruptors in the prescription drug space, like Mark Cuban, and also the saga surrounding the Alzheimer’s drug Aduhelm. You’ll find links to the articles here:
I love the new way the link opens to what is basically your page. Excellent article and really good news. It was a bit hard for me to read in that memories are tied up in the non small cell lung treatments. Mac started his battle taking tarceva (pill form) at around $8,000/month with an out of pocket of close to $3,000/month. Dana helped us get a grant for some.
By the time Mac’s oncologist suggested opdivo, he had Medicare with a BCBS supplement. Opdivo had not been approved by Medicare so Dana paid the cost until it was
The opdivo theory was that the cancer would grow and then the persons body would recognize it and be trained to attack it. That was before they learned a second chemo had to be used in conjunction with opdivo. So the cancer grew but there was no second chemo to assist. And it sucked. If there is any positive, Mac helped the medical profession to learn what was missing.
Now, as your article shows, folks are working to bring these ans other drugs to a price point that is based in reality
Thanks TK.
C-19 for 2-11 is ready.
Comments are closed.
Your no-hype southeastern New England weather blog!
For those interested, my Forbes articles this month have been focused on price disruptors in the prescription drug space, like Mark Cuban, and also the saga surrounding the Alzheimer’s drug Aduhelm. You’ll find links to the articles here:
https://www.forbes.com/sites/joshuacohen/?sh=3a013a88594c
I love the new way the link opens to what is basically your page. Excellent article and really good news. It was a bit hard for me to read in that memories are tied up in the non small cell lung treatments. Mac started his battle taking tarceva (pill form) at around $8,000/month with an out of pocket of close to $3,000/month. Dana helped us get a grant for some.
By the time Mac’s oncologist suggested opdivo, he had Medicare with a BCBS supplement. Opdivo had not been approved by Medicare so Dana paid the cost until it was
The opdivo theory was that the cancer would grow and then the persons body would recognize it and be trained to attack it. That was before they learned a second chemo had to be used in conjunction with opdivo. So the cancer grew but there was no second chemo to assist. And it sucked. If there is any positive, Mac helped the medical profession to learn what was missing.
Now, as your article shows, folks are working to bring these ans other drugs to a price point that is based in reality
Thanks TK.
C-19 for 2-11 is ready.